Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura (Q33377517)

26 July 2017

Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

1 reference

1 reference

R S Camilleri

1

1 reference

26 July 2017

H Cohen

2

1 reference

26 July 2017

I J Mackie

3

1 reference

26 July 2017

M Scully

4

1 reference

26 July 2017

R D Starke

5

1 reference

26 July 2017

J T B Crawley

6

1 reference

26 July 2017

D A Lane

7

1 reference

26 July 2017

S J Machin

8

1 reference

26 July 2017

language of work or name

1 reference

20 November 2007

1 reference

Journal of Thrombosis and Haemostasis

26 July 2017

1 reference

26 July 2017

6

1 reference

26 July 2017

2

1 reference

26 July 2017

331-338

1 reference

Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Partial amino acid sequence of purified von Willebrand factor-cleaving protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Mechanisms of the interaction between two ADAMTS13 gene mutations leading to severe deficiency of enzymatic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

ADAMTS13 substrate recognition of von Willebrand factor A2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

O-fucosylation is required for ADAMTS13 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

Thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02846.X

10.1111/J.1538-7836.2007.02846.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference